Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 28, 2026

Starbucks (NASDAQ:SBUX) Beats Expectations in Strong Q1 CY2026, Stock Soars

View original at finance.yahoo.com
“Free Cash Flow was $91.8 million, up from -$297.2 million in the same quarter last year”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Starbucks' menu offerings will face some demand challenges in the next 12 months, given the projected deceleration in revenue growth.

    60% confidence
  • Same-store sales rose 6.2% year on year in Q1 CY2026, a significant recovery from -1% in the same quarter last year.

    60% confidence
  • Sell-side analysts expect Starbucks revenue to grow 1.3% over the next 12 months, a deceleration versus the last seven years.

    60% confidence
  • Starbucks grew sales at a 6% compounded annual growth rate over the last seven years.

    60% confidence
  • Operating margin improved to 8.7% in Q1 CY2026, up from 6.9% in the same quarter last year.

    60% confidence
  • Free cash flow improved to $91.8 million in Q1 CY2026, up from -$297.2 million in the same quarter last year.

    60% confidence
  • Analyst consensus revenue estimate for Q1 CY2026 was $9.14 billion.

    60% confidence
  • Adjusted EBITDA was $1.19 billion, beating analyst estimates of $1.18 billion by 0.8%, with a 12.5% EBITDA margin.

    60% confidence
  • Starbucks revenue grew 8.8% year on year to $9.53 billion in Q1 CY2026, beating analyst estimates of $9.14 billion by 4.3%.

    60% confidence
  • Starbucks scale gives it negotiating leverage with suppliers, enabling it to source ingredients at a lower cost, but limits incremental growth due to finite restaurant locations.

    60% confidence
  • Analyst consensus adjusted EPS estimate for Q1 CY2026 was $0.44.

    60% confidence
  • Adjusted EPS of $0.50 was 13.6% above analyst consensus estimate of $0.44 in Q1 CY2026.

    60% confidence

Data points we hold from this source

Starbucks Corporation · margin12.5 percent
Starbucks Corporation · cash91.8 USD
Starbucks Corporation · employee count41129 locations
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Starbucks (NASDAQ:SBUX) Beats Expectations in Strong Q1 CY2026, Stock Soars — Source | Via News | Finance Via News